The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Parvo Shield (Canada)This page contains information on Parvo Shield for veterinary use.
The information provided typically includes the following:
- Parvo Shield Indications
- Warnings and cautions for Parvo Shield
- Direction and dosage information for Parvo Shield
Parvo ShieldThis treatment applies to the following species:
For Use In Animals Only
Parvo Shield Indications
For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus.
ADJUVANT: Aluminum hydroxide
Directions For Use
Shake well before using. Administer 2 mL intramuscularly or subcutaneously 3-4 weeks prior to breeding. Revaccinate prior to each subsequent breeding. Vaccinate boars annually.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
U.S. Vet. License No. 303
Novartis Animal Health US, Inc.
©2012 Novartis; Registered trademark of Novartis AG, used under license.
Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9
NAC No.: 1231079.2
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Elanco Canada Limited Customer Service Telephone:||800-387-6325|
|Elanco Canada Limited Customer Service Fax:||800-827-5782|
|Every effort has been made to ensure the accuracy of the Parvo Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-03-29